Molecular targets of aspirin and cancer prevention

British Journal of Cancer

Volumn 111, Issue 1, 2014, Pages 61-67

  Alfonso, L ^a   Ai, G ^b   Spitale, R C ^c   Bhat, G J ^b  

^a D'YOUVILLE COLLEGE   (United States)

^b SOUTH DAKOTA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

acetylation; aspirin; biomolecules; chemoprevetion; colon cancer; salicylic acid

Indexed keywords

ACETYL COENZYME A; ACETYLSALICYLIC ACID; CELL PROTEIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DRUG METABOLITE; NONSTEROID ANTIINFLAMMATORY AGENT; RNA; SALICYLIC ACID; TRANSCRIPTION FACTOR;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER PREVENTION; COLON CANCER; COLORECTAL CANCER; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; INTESTINE EPITHELIUM CELL; LIVER CANCER; LUNG CANCER; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PROCESSING; REVIEW; SKIN CANCER;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; ASPIRIN; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS;

EID: 84904111180     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.271     Document Type: Review

References (82)

1. Abdelrahim M, Safe S (2005) Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. Mol Pharmacol 68(2): 317-329.
2. Alfonso LF, Srivenugopal KS, Arumugam TV, Abbruscato TJ, Weidanz JA, Bhat GJ (2009a) Aspirin inhibits camptothecin-induced p21CIP1 levels and potentiates apoptosis in human breast cancer cells. Int J Oncol 34(3): 597-608.
3. Alfonso LF, Srivenugopal KS, Bhat GJ (2009b) Does aspirin acetylate multiple cellular proteins?(Review). Mol Med Rep 2(4): 533-537.
4. Archer SY, Hodin RA (1999) Histone acetylation and cancer. Curr Opin Genet Dev 9(2): 171-174.
5. Arnold JT, Wilkinson BP, Sharma S, Steele VE (1995) Evaluation of chemopreventive agents in different mechanistic classes using a rat tracheal epithelial cell culture transformation assay. Cancer Res 55(3): 537-543.
6. Bastiaannet E, Sampieri K, Dekkers OM, de Craen AJ, van Herk-Sukel MP, Lemmens V, van den Broek CB, Coebergh JW, Herings RM, van de Velde CJ, Fodde R, Liefers GJ (2012) Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer 106(9): 1564-1570.
7. Bateman LA, Zaro BW, Miller SM, Pratt MR (2013) An alkyne-aspirin chemical reporter for the detection of aspirin-dependent protein modification in living cells. J Am Chem Soc 135(39): 14568-14573.
8. Bellosillo B, Piqué M, Barragán M, Castaño E, Villamor N, Colomer D, Montserrat E, Pons G, Gil J (1998) Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 92(4): 1406-1414.
9. Bennett BD, Kimball EH, Gao M, Osterhout R, Van Dien SJ, Rabinowitz JD (2009) Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli. Nat Chem Biol 5(8): 593-599.
10. Bjornsson T, Schneider D, Berger H (1989) Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels. J Pharmacol Exp Ther 250(1): 154-161.
11. Bos CL, Kodach LL, van den Brink GR, Diks SH, van Santen MM, Richel DJ, Peppelenbosch MP, Hardwick JC (2006) Effect of aspirin on the Wnt/b-catenin pathway is mediated via protein phosphatase 2A. Oncogene 25(49): 6447-6456.
12. Bos JL (1989) Ras oncogenes in human cancer: A review. Cancer Res 49(17): 4682-4689.
13. Bridges KR, Schmidt GJ, Jensen M, Cerami A, Bunn HF (1975) The acetylation of hemoglobin by aspirin. In vitro and in vivo. J Clin Invest 56(1): 201-207.
14. Caterson RJ, Duggin GG, Horvath J, Mohandas J, Tiller D (1978) Aspirin, protein transacetylation and inhibition of prostaglandin synthetase in the kidney. Br J Pharmacol 64(3): 353-358.
15. Chan AT, Ogino S, Fuchs CS (2009) Aspirin use and survival after diagnosis of colorectal cancer. JAMA 302(6): 649-658.
16. Chan TA, Morin PJ, Vogelstein B, Kinzler KW (1998) Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci 95(2): 681-686.
17. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325(5942): 834-840.
18. Claria J, Serhan CN (1995) Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci 92(21): 9475-9479.
19. Dikshit P, Chatterjee M, Goswami A, Mishra A, Jana NR (2006) Aspirin induces apoptosis through the inhibition of proteasome function. J Biol Chem 281(39): 29228-29235.
20. Dixon DA, Blanco FF, Bruno A, Patrignani P (2013) Mechanistic aspects of COX-2 expression in colorectal neoplasia. Recent Results Cancer Res 191: 7-37.
21. Dovizio M, Bruno A, Tacconelli S, Patrignani P (2013) Mode of action of aspirin as a chemopreventive agent. Recent Results Cancer Res 191: 39-65.
22. Drahl C, Cravatt BF, Sorensen EJ (2005) Protein-reactive natural products. Angew Chem Int Ed Engl 44(36): 5788-5809.
23. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107(4): 1183-1188.
24. Ferrandez A, Piazuelo E, Castells A (2012) Aspirin and the prevention of colorectal cancer. Best Pract Res Clin Gastroenterol 26(2): 185-195.
25. Fica SM, Tuttle N, Novak T, Li NS, Lu J, Koodathingal P, Dai Q, Staley JP, Piccirilli JA (2013) RNA catalyses nuclear pre-mRNA splicing. Nature 503(7475): 229-234.
26. Gamba CA, Swetter SM, Stefanick ML, Kubo J, Desai M, Spaunhurst KM, Sinha AA, Asgari MM, Sturgeon S, Tang JY (2013) Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: The Women's Health Initiative. Cancer 119(8): 1562-1569.
27. Gay LJ, Felding-Habermann B (2011) Contribution of platelets to tumour metastasis. Nat Rev Cancer 11(2): 123-134.
28. Giardiello FM, Casero Jr RA,Hamilton SR, Hylind LM, Trimbath JD, Geiman DE, Judge KR, Hubbard W, Offerhaus GJA, Yang VW (2004) Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis. Gastroenterology 126(2): 425-431.
29. Guo M, Spitale RC, Volpini R, Krucinska J, Cristalli G, Carey PR, Wedekind JE (2009) Direct Raman measurement of an elevated base pKa in the active site of a small ribozyme in a precatalytic conformation. J Am Chem Soc 131(36): 12908-12909.
30. Gupta RA, DuBois RN (1998) Aspirin, NSAIDS, and colon cancer prevention: Mechanisms? Gastroenterology 114(5): 1095-1098.
31. Harris RE, Beebe-Donk J, Doss H, Doss DB (2005) Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: A critical review of non-selective COX-2 blockade (review). Oncol Rep 13(4): 559-583.
32. Hawkins D, Pinckard RN, Farr RS (1968) Acetylation of human serum albumin by acetylsalicylic acid. Science 160(3829): 780-781.
33. Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE (2010) Aspirin intake and survival after breast cancer. J Clin Oncol 28(9): 1467-1472.
34. Kaiser J (2012) Will an aspirin a day keep cancer away? Science 337(6101): 1471-1473.
35. Kopp E, Ghosh S (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265(5174): 956-959.
36. Kouraklis G, Theocharis S (2003) Histone acetylation and cancer. Acta Oncol 42(7): 792.
37. Lai TS, Davies C, Greenberg CS (2010) Human tissue transglutaminase is inhibited by pharmacologic and chemical acetylation. Protein Sci 19(2): 229-235.
38. Law BK, Waltner-Law ME, Entingh AJ, Chytil A, Aakre ME, Norgaard P, Moses HL (2000) Salicylate-induced growth arrest is associated with inhibition of p70s6k and down-regulation of c-myc, cyclin D1, cyclin A, and proliferating cell nuclear antigen. J Biol Chem 275(49): 38261-38267.
39. Leonards JR (1962) Presence of acetylsalicylic acid in plasma following oral ingestion of aspirin. Proc Soc Exp Biol Med 110(2): 304-308.
40. Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian ZR, Baba Y, Shima K, Sun R, Nosho K, Meyerhardt JA, Giovannucci E, Fuchs CS, Chan AT, Ogino S (2012) Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 367(17): 1596-1606.
41. Lunde BM, Moore C, Varani G (2007) RNA-binding proteins: Modular design for efficient function. Nat Rev Mol Cell Biol 8(6): 479-490.
42. Marimuthu S, Chivukula RS, Alfonso LF, Moridani M, Hagen FK, Bhat GJ (2011) Aspirin acetylates multiple cellular proteins in HCT-116 colon cancer cells: Identification of novel targets. Int J Oncol 39(5): 1273-1283.
43. Marmorstein R (2001) Structure and function of histone acetyltransferases. Cell Mol Life Sci 58(5-6): 693-703.
44. Marmorstein R, Roth SY (2001) Histone acetyltransferases: Function, structure, and catalysis. Curr Opin Genet Dev 11(2): 155-161.
45. McCarty MF, Block KI (2006) Preadministration of high-dose salicylates, suppressors of NF-kB activation, may increase the chemosensitivity of many cancers: An example of proapoptotic signal modulation therapy. Integr Cancer Ther 5(3): 252-268.
46. McGinnis JL, Dunkle JA, Cate JH, Weeks KM (2012) The mechanisms of RNA SHAPE chemistry. J Am Chem Soc 134(15): 6617-6624.
47. Merino EJ, Wilkinson KA, Coughlan JL, Weeks KM (2005) RNA structure analysis at single nucleotide resolution by selective 2'-hydroxyl acylation and primer extension (SHAPE). J Am Chem Soc 127(12): 4223-4231.
48. Moellering RE, Cravatt BF (2013) Functional lysine modification by an intrinsically reactive primary glycolytic metabolite. Science 341(6145): 549-553.
49. Moss WN (2013) Computational prediction of RNA secondary structure. Methods Enzymol 530: 3-65.
50. Moyad MA (2001) An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: Part II. Semin Urol Oncol 19(4): 306-316.
51. Nunez L, Valero RA, Senovilla L, Sanz-Blasco S, Garcia-Sancho J, Villalobos C (2006) Cell proliferation depends on mitochondrial Ca2\+ uptake: Inhibition by salicylate. J Physiol 571(Pt 1): 57-73.
52. Pan MR, Chang HC, Hung WC (2008) Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases. Cell Signal 20(6): 1134-1141.
53. Pathi S, Jutooru I, Chadalapaka G, Nair V, Lee SO, Safe S (2012) Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors. PloS one 7(10): E48208.
54. Pinckard RN, Hawkins D, Farr RS (1968) In vitro acetylation of plasma proteins, enzymes and DNA by aspirin. Nature 219(5149): 68-69.
55. Qin W, Smith JB, Smith DL (1993) Reaction of aspirin with cysteinyl residues of lens gamma-crystallins: A mechanism for the proposed anti-cataract effect of aspirin. Biochim Biophys Acta 1181(2): 103-110.
56. Rainsford K, Schweitzer A, Brdne K (1983) Distribution of the acetyl compared with the salicyl moiety of acetylsalicylic acid: Acetylation of macromolecules in organs wherein side-effects are manifest. Biochem Pharmacol 32(7): 1301-1308.
57. Rao CV, Reddy BS (2004) NSAIDs and chemoprevention. Curr Cancer Drug Targets 4(1): 29-42.
58. Roth GJ, Stanford N, Majerus PW (1975) Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci 72(8): 3073-3076.
59. Rothwell PM, Price JF, Fowkes FGR, Zanchetti A, Roncaglioni MC, Tognoni G, Lee R, Belch JF, Wilson M, Mehta Z (2012) Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 379(9826): 1602-1612.
60. Rothwell PM, Wilson M, Elwin C-E, Norrving B, Algra A, Warlow CP, Meade TW (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376(9754): 1741-1750.
61. Ryder SP, Oyelere AK, Padilla JL, Klostermeier D, Millar DP, Strobel SA (2001) Investigation of adenosine base ionization in the hairpin ribozyme by nucleotide analog interference mapping. RNA 7(10): 1454-1463.
62. Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y, Hollenbeck AR, Freedman ND, McGlynn KA (2012) Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst 104(23): 1808-1814.
63. Sawaoka H, Tsuji S, Tsujii M, Gunawan ES, Sasaki Y, Kawano S, Hori M (1999) Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest 79(12): 1469-1477.
64. Sciulli M, Filabozzi P, Tacconelli S, Padovano R, Ricciotti E, Capone M, Grana M, Carnevale V, Patrignani P (2005) Platelet activation in patients with colorectal cancer. Prostaglandins Leukot Essent Fatty Acids 72(2): 79-83.
65. Shiff SJ, Koutsos MI, Qiao L, Rigas B (1996) Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis. Exp Cell Res 222(1): 179-188.
66. Shiff SJ, Shivaprasad P, Santini DL (2003) Cyclooxygenase inhibitors: Drugs for cancer prevention. Curr Opin Pharmacol 3(4): 352-361.
67. Simon GM, Niphakis MJ, Cravatt BF (2013) Determining target engagement in living systems. Nat Chem Biol 9(4): 200-205.
68. Spitz GA, Furtado CM, Sola-Penna M, Zancan P (2009) Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity. Biochem Pharmacol 77(1): 46-53.
69. Stark LA, Reid K, Sansom OJ, Din FV, Guichard S, Mayer I, Jodrell DI, Clarke AR, Dunlop MG (2007) Aspirin activates the NF-kappaB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer. Carcinogenesis 28(5): 968-976.
70. Thun MJ, Jacobs EJ, Patrono C (2012) The role of aspirin in cancer prevention. Nat Rev Clin Oncol 9(5): 259-267.
71. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231(25): 232-235.
72. Veitonmaki T, Tammela TL, Auvinen A, Murtola TJ (2013) Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level. Eur J Cancer 49(4): 938-945.
73. Velikyan I, Acharya S, Trifonova A, Foldesi A, Chattopadhyaya J (2001) The pK(a)'s of 2'-hydroxyl group in nucleosides and nucleotides. J Am Chem Soc 123(12): 2893-2894.
74. Wang C, Fu M, Mani S, Wadler S, Senderowicz AM, Pestell RG (2001) Histone acetylation and the cell-cycle in cancer. Front biosci 6: D610-D629.
75. Wang C, Weerapana E, Blewett MM, Cravatt BF (2014) A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles. Nat methods 11(1): 79-85.
76. Wang Q, Zhang Y, Yang C, Xiong H, Lin Y, Yao J, Li H, Xie L, Zhao W, Yao Y (2010) Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science 327(5968): 1004-1007.
77. Williams CS, Smalley W, DuBois RN (1997) Aspirin use and potential mechanisms for colorectal cancer prevention. J Clinical Invest 100(6): 1325-1329.
78. Xu W, Li Y, Liu C, Zhao S (2013) Protein lysine acetylation guards metabolic homeostasis to fight against cancer. Oncogene 33(18): 2279-2285.
79. Xu X-M, Sansores-Garcia L, Chen X-M, Matijevic-Aleksic N, Du M, Wu KK (1999) Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc Natl Acad Sci 96(9): 5292-5297.
80. Yin M-J, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of IkB kinase-b. Nature 396(6706): 77-80.
81. Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T, Yao J, Zhou L, Zeng Y, Li H (2010) Regulation of cellular metabolism by protein lysine acetylation. Science 327(5968): 1000-1004.
82. Zimmermann KC, Waterhouse NJ, Goldstein JC, Schuler M, Green DR (2000) Aspirin induces apoptosis through release of cytochrome c from mitochondria. Neoplasia 2(6): 505-513.